Related Articles
Top Research in Rheumatoid Arthritis Presented at ACR Convergence 2024
Why this research is relevant to clinicians today & researchers in the future WASHINGTON, D.C.—The ACR Convergence 2024 meeting in Washington, D.C., reflected the continued advancement of science and practical research in the field of rheumatoid arthritis. Highlights this year centered on new RA treatments and new uses of existing treatments; the use of artificial…
TNF Blockade for SLE
Reckless approach versus missed opportunity?
Are We Playing It Safe?
Tumor necrosis factor alpha inhibition and the risk of solid malignancies
Target Remission
Strategies to identify and track remission in your RA patients